Xinling Medical Technology

Xinling Medical is a China-based medical technology company focused on developing innovative interventional solutions for structural heart disease and heart failure. The company's primary product portfolio includes transcatheter mitral valve replacement (TMVR) systems, transcatheter tricuspid valve replacement (TTVR) systems, and interatrial shunt devices. These minimally invasive technologies are designed to address significant unmet clinical needs in patients with complex cardiovascular conditions who are at high risk for traditional open-heart surgery. Xinling Medical has secured substantial backing from prominent venture capital firms to accelerate its clinical development and regulatory pathways in the Chinese market.